BIRC5 and non-small cell lung carcinoma: Zhang et al., in a meta-analysis of 2703 NSCLC patients from 28 studies, showed that survivin overexpression is associated with a shorter survival (HR = 2.03, 95% CI: 1.78–2.33, Egger’s test, p = 0.24).